Variants in DDX53 and other X-linked genes offer genetic insights into the higher prevalence of ASD in males. A recent study ...
SciSparc Ltd., a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, has received renewed approval from the ...
SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the ...